J&J’s DePuy Synthes launches Purevue visualization system

This article was originally published here

DePuy Synthes

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it launched the Purevue visualization system imaging platform designed for minimally invasive endoscopic surgery.

The newly launched system combines a light source, image processor and local image management, looking to reduce the equipments footprint in the operating room, DePuy said. The system also includes an autoclavable camera head, touch-screen navigation and customizable settings for minimally invasive surgery applications.

DePuy said the Purevue visualization system completes its capital equipment offering in arthroscopy, which includes its Vapr Vue radiofrequency system and FMS Vue fluid management and tissue debridement system.

“With Americans living longer and seeking shorter recovery times, the call for minimally invasive procedures is accelerating. We are committed to bringing forward innovation that responds to evolving patient needs and the Purevue Visualization System is an example of how our advanced technologies enable high quality patient care,” DePuy Synthes Mitek sports medicine global platform leader Stephanie Chamberlain said in a press release.

In late October, DePuy Synthes said it launched the TFNA augmentation system designed to treat patients with hip fractures who have poor bone quality.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply